ABO blood group and risk of pancreatic cancer: A study in Shanghai and meta-analysis

American Journal of Epidemiology

Volumn 177, Issue 12, 2013, Pages 1326-1337

  Risch, Harvey A ^a   Lu, Lingeng ^a   Wang, Jing ^b   Zhang, Wei ^b   Ni, Quanxing ^c   Gao, Yu Tang ^b   Yu, Herbert ^a,d  

^a YALE UNIVERSITY   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

ABO blood group system; Asia; case control studies; meta analysis; pancreatic neoplasms

Indexed keywords

BLOOD; CANCER; ENDEMIC SPECIES; GENE EXPRESSION; HEALTH RISK; META-ANALYSIS; URBAN POPULATION;

BLOOD GROUP ABO SYSTEM; CANCER RISK; CHINA; CYTOTOXIN ASSOCIATED GENE A; GENE; HUMAN; META ANALYSIS; PANCREAS CANCER; POPULATION RESEARCH; REVIEW; SYSTEMATIC REVIEW;

ABO BLOOD GROUP SYSTEM; ASIA; CASE-CONTROL STUDIES; META-ANALYSIS; PANCREATIC NEOPLASMS;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; ALLELES; ANTIGENS, BACTERIAL; ASIAN CONTINENTAL ANCESTRY GROUP; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

ASIA; CHINA; SHANGHAI;

HELICOBACTER PYLORI;

EID: 84878834758     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws458     Document Type: Review

References (63)

1. Gao Y-T, LuW. Cancer Incidence, Mortality and Survival Rates in Urban Shanghai (1973-2000). Shanghai, China: Second Military Medical University Press; 2007.
2. Gong Z, Holly EA, Bracci PM. Survival in population-based pancreatic cancer patients: San Francisco Bay area, 1995-1999. Am J Epidemiol. 2011;174(12):1373-1381.
3. Bosetti C, Lucenteforte E, Silverman DT, et al. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol. 2012;23(7):1880-1888.
4. Lowenfels AB, Maisonneuve P. Pancreatic cancer: development of a unifying etiologic concept. Ann N Y Acad Sci. 1999;880:191-200.
5. Case J, Raeburn C,WaltherWW. Blood groups in relation to malignant diseases. Lancet. 1956;271(6950):970-972.
6. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies ABO blood group susceptibility variants for pancreatic cancer. Nat Genet. 2009;41(9):986-990.
7. Nakao M, Matsuo K, Hosono S, et al. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population. Cancer Sci. 2011;102(5):1076- 1080.
8. Patnaik SK, HelmbergW, Blumenfeld OO. BGMUT: NCBI dbRBC database of allelic variations of genes encoding antigens of blood group systems. Nucleic Acids Res. 2012; 40(1):D1023-D1029.
9. Risch HA, Yu H, Lu L, et al. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a casecontrol study. J Natl Cancer Inst. 2010;102(7):502-505.
10. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(6):e1000097.
11. AVIS. The blood groups [in Italian]. http://www.avismi.it/download/pdf/ aem/2009-01-04.pdf ). (Accessed March 5, 2012).
12. Iodice S, Maisonneuve P, Botteri E, et al. ABO blood group and cancer. Eur J Cancer. 2010;46(18):3345-3350.
13. Wolpin BM, Kraft P, Xu M, et al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3140- 3149.
14. Dandona M, Gao F, Lineham DC, et al. Re: "ABO blood group and the risk of pancreatic cancer" [letter]. J Natl Cancer Inst. 2010;102(2):135-137.
15. Rizzato C, Campa D, Giese N, et al. Pancreatic cancer susceptibility loci and their role in survival. PLoS One. 2011; 6(11):e27921.
16. Kokic NZ, Adanja JB, Vlajinac DH, et al. Case-control study of pancreatic cancer in Serbia, Yugoslavia. Neoplasma. 1996;43(5):353-356.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
18. Newell GR, Gordon JE, Monlezun AP, et al. ABO blood groups and cancer. J Natl Cancer Inst. 1974;52(5):1425-1430.
19. Macafee AL. ABO blood groups and carcinoma of pancreas. Ulster Med J. 1964;33(2):129-131.
20. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. suppl):33S-39S
21. Perez-Perez GI, Rothenbacher D, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2004;9(1 suppl): 1S-6S.
22. Epplein M, Signorello LB, ZhengW, et al. Race, African ancestry, and Helicobacter pylori infection in a low-income United States population. Cancer Epidemiol Biomarkers Prev. 2011;20(5):826-834.
23. Wang D-S, Chen D-L, Ren C, et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer. 2012;131(2):461-468.
24. Gong Y, Yang Y-S, Zhang X-M, et al. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China. World J Gastroenterol. 2012;18(6):563-569.
25. Zhou G-Z, Li Z-S. Clinical epidemiological research on pancreatic cancer: an analysis of 1027 cases. World Chin J Digestol. 2005;13(1):55-60.
26. Ben Q, Wang K, Yuan Y, et al. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int J Cancer. 2011; 128(5):1179-1186.
27. Wolpin BM, Kraft P, Gross M, et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res. 2010;70(3):1015-1023.
28. Aird I, Lee DR, Roberts JAF. ABO blood groups and cancer of oesophagus, cancer of pancreas, and pituitary adenoma. BMJ. 1960;1(5180):1163-1166.
29. Moniwa H. Statistical studies on the correlation between the ABO-blood groups and some diseases. Tohoku J Exp Med. 1960;72:275-289.
30. Rai S, Saronwala KC, Singh R. ABO blood groups in cancer of the gastro-intestinal tract. Indian J Cancer. 1972;9(1): 97-100.
31. Mikhailichenko VA. ABO blood-group system in patients with pancreatic cancer [in Russian]. Vopr Onkol. 1976;22(12):72-73.
32. Annese V, Minervini M, Gabbrielli A, et al. ABO blood groups and cancer of the pancreas. Int J Pancreatol. 1990; 6(2):81-88.
33. Vioque J,Walker AM. Pancreatic cancer and ABO blood type: a case-control study [in Spanish]. Med Clin (Barc). 1991; 96(20):761-764.
34. Guleria K, Singh HP, Kaur H, et al. ABO blood groups in gastrointestinal tract (GIT) and breast carcinoma patients. Anthropologist. 2005;7(3):189-192.
35. Greer JB, Yazer MH, Raval JS, et al. Significant association between ABO blood group and pancreatic cancer. World J Gastroenterol. 2010;16(44):5588-5591.
36. Low SK, Kuchiba A, Zembutsu H, et al. Genome-wide association study of pancreatic cancer in Japanese population. PLoS One. 2010;5(7):e11824.
37. Engin H, Bilir C, Üstün H, et al. ABO blood group and risk of pancreatic cancer in a Turkish population inWestern Black Sea region. Asian Pac J Cancer Prev. 2012;13(1):131-133.
38. Rahbari NN, Bork U, Hinz U, et al. ABO blood group and prognosis in patients with pancreatic cancer. BMC Cancer. 2012;12:319
39. Vogel F, Krüger J. Statistical relationships between the ABO blood groups and diseases with the exception of the infectious diseases [in German]. Blut. 1968;16(6):351-376.
40. Barbalic M, Dupuis J, Dehghan A, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet. 2010;19(9):1863-1872.
41. Melzer D, Perry JRB, Hernandez D, et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet. 2008;4(5):e1000072.
42. Paré G, Chasman DI, Kellogg M, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6578 women. PLoS Genet. 2008;4(7):e1000118.
43. Paterson AD, Lopes-Virella MF,Waggott D, et al. Genomewide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Arterioscler Thromb Vasc Biol. 2009;29(11):1958-1967.
44. Qi L, Cornelis MC, Kraft P, et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet. 2010;19(9):1856-1862.
45. Yamamoto F, McNeill PD, Hakomori S. Human histo-blood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal. Biochem Biophys Res Commun. 1992; 187(1):366-374.
46. Clausen H, Levery SB, Nudelman E, et al. Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction. Proc Natl Acad Sci USA 1985;82(4): 1199-1203.
47. Petersen GM, Amundadottir L, Fuchs CS, et al. A genomewide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010;42(3):224-228.
48. Yip SP. Single-tube multiplex PCR-SSCP analysis distinguishes 7 common ABO alleles and readily identifies new alleles. Blood. 2000;95(4):1487-1492.
49. Nishimukai H, Fukumori Y, Okiura T, et al. Genotyping of the ABO blood group system: analysis of nucleotide position 802 by PCR-RFLP and the distribution of ABO genotypes in a German population. Int J Legal Med. 1996;109(2):90-93.
50. Nishimukai H, Fukumori Y, Tsujimura R, et al. Rare alleles of the ABO blood group system in two European populations. Legal Med. 2009;11(1 suppl):479S-481S.
51. Zhu F, Tao S, Xu X, et al. Distribution of ABO blood group allele and identification of three novel alleles in the Chinese Han population. Vox Sang. 2010;98(4):554-559.
52. Fukumori Y, Ohnoki S, Shibata H, et al. Suballeles of the ABO blood group system in a Japanese population. Hum Hered. 1996;46(2):85-91.
53. Kobayashi K, Iwasaki M, Anan K, et al. An analysis of polymorphism for the ABO blood group genes in a Japanese population based on polymerase chain reaction. Anthropol Sci. 1999;107(2):109-121.
54. Chen Z, Zhao T, Zhang G. ABO blood group distribution in the Chinese population [in Chinese]. Hereditas (Beijing).
55. Fujita Y, Tanimura M, Tanaka K. The distribution of the ABO blood groups in Japan. Jpn J Hum Genet. 1978; 23(2):63-109.
56. Wu C, Miao X, Huang L, et al. Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet. 2012; 44(1):62-66.
57. Risch HA. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst. 2003;95:948-960.
58. Alkout AM, Blackwell CC,Weir DM, et al. Isolation of a cell surface component of Helicobacter pylori that binds H type 2, Lewis a, and Lewis b antigens. Gastroenterology. 1997; 112(4):1179-1187.
59. Risch HA. Pancreatic cancer: Helicobacter pylori colonization, N-nitrosamine exposures, and ABO blood group. Mol Carcinog. 2012;51(1):109-118.
60. Bond CJ. On auto-haemagglutination: a contribution to the physiology and pathology of the blood. Br Med J. 1920; 2(3129):925-927.
61. Bond CJ. On auto-haemagglutination: a contribution to the physiology and pathology of the blood. Br Med J. 1920; 2(3130):973-976.
62. Beckman L. A Contribution to the Physical Anthropology and Population Genetics of Sweden. Lund, Sweden: Berlingska Boktryck; 1959:21.
63. Bloodbook.com. Racial and ethnic distribution of ABO blood types. http://www.bloodbook.com/world-abo.html). (Accessed July 23, 2012).